Suiseng Diff/A

RSS

clostridioides difficile / clostridium perfringens vaccine, inactivated

Authorised
This medicine is authorised for use in the European Union.

Overview

Suiseng Diff/A is a veterinary vaccine given to sows (female pigs that have already given birth to piglets) or gilts (female pigs that have not yet given birth to piglets) to protect their offspring from intestinal disease caused by toxins produced by the bacteria Clostridioides difficile (toxins A and B) and Clostridium perfringens type A (alpha toxin). Suiseng Diff/A contains versions of the toxins that have been inactivated so they cannot cause disease, called toxoid A, toxoid B and alpha toxoid.

This EPAR was last updated on 24/01/2022

Authorisation details

Product details
Name
Suiseng Diff/A
Agency product number
EMEA/V/C/005596
Active substance
  • Clostridioides difficile toxoid A
  • Clostridioides difficile toxoid B
  • Clostridium perfringens, type A, alpha toxoid
International non-proprietary name (INN) or common name
  • clostridioides difficile
  • clostridium perfringens vaccine, inactivated
Species
Pigs
Anatomical therapeutic chemical veterinary (ATCvet) codes
QI09AB12
Publication details
Marketing-authorisation holder
Laboratorios Hipra, S.A.
Date of issue of marketing authorisation valid throughout the European Union
07/12/2021
Contact address

Avda. La Selva, 135
17170 Amer
Girona
Spain

Product information

Suiseng Diff/A - EMEA/V/C/005596 -

Product information documents contain:

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

Immunologicals for Suidae, inactivated bacterial vaccines for pigs, clostridium

Therapeutic indication

For the passive immunisation of neonatal piglets by means of the active immunisation of breeding sows and gilts:
- to prevent mortality and reduce clinical signs and macroscopic lesions caused by Clostridioides difficile toxins A and B.
- to reduce clinical signs and macroscopic lesions caused by Clostridium perfringens type A, alpha toxin.

Assessment history

How useful was this page?

Add your rating